Pediatr Gastroenterol Hepatol Nutr.  2017 Mar;20(1):22-26. 10.5223/pghn.2017.20.1.22.

Pooled Analysis of the Cow's Milk-related-Symptom-Score (CoMiSSâ„¢) as a Predictor for Cow's Milk Related Symptoms

Affiliations
  • 1Department of Pediatrics, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium. yvan.vandenplas@uzbrussel.be
  • 2Nestlé Health Science, Vevey, Switzerland.
  • 3United Pharmaceuticals/Novalac, Paris, France.
  • 4Cytel, Cambridge, MA, USA.

Abstract

PURPOSE
The diagnosis of cow's milk (CM) allergy is a challenge. The Cow's Milk-related-Symptom-Score (CoMiSSâ„¢) was developed to offer primary health care providers a reliable diagnostic tool for CM related symptoms. The predictive prospective value of the CoMiSSâ„¢ was evaluated in three clinical trials.
METHODS
Pooled analyses of the three studies were conducted based on regressing the results of the month-1 challenge test on the month-1 CoMiSSâ„¢, adjusting for baseline CoMiSSâ„¢ using a logistic regression model. In addition a logistic regression model was also fitted to the month-1 challenge test result with the change in CoMiSSâ„¢ from baseline as a predictor.
RESULTS
Results suggest that infants having a low CoMiSSâ„¢ (median, 5) after 1 month dietary treatment free from intact CM protein have a significant risk of having a positive challenge test (odds ratio, 0.83; 95% confidence interval, 0.75-0.93; p=0.002). Pooled data suggest that the change in CoMiSSâ„¢ from baseline to month-1 can predict CM related symptoms as a confirmed diagnosis according to the challenge test at month-1. However, in order to validate such a tool, infants without CM related symptoms would also need to be enrolled in a validation trial. A concern is that it may not be ethical to expose healthy infants to a therapeutic formula and a challenge test.
CONCLUSION
Pooled data analysis emphasizes that the CoMiSSâ„¢ has the potential to be of interest in infants suspected to have CM-related-symptoms. A prospective validation trial is needed.

Keyword

Cow's milk protein allergy; Cow's milk-related-symptom-score extensive hydrolysate

MeSH Terms

Diagnosis
Humans
Hypersensitivity
Infant
Logistic Models
Milk*
Primary Health Care
Prospective Studies
Statistics as Topic

Figure

  • Fig. 1 The receiver operating characteristics (ROC)-curve predicting probability to have positive challenge test. A typical ROC curve for predicting month-1 challenge test result based on the change in Cow's Milk-related-Symptom-Score (CoMiSS™) from baseline to month-1 and based on data generated to cover the entire range of the CoMiSS™ (0-12). The area under the curve (AUC) of the ROC curve is 0.88. The thin straight line depicts random prediction with an AUC of 0.5.


Cited by  1 articles

Cow's Milk-related Symptom Score as a predictive tool for cow's milk allergy in Indian children aged 0–24 months
Rajniti Prasad, Ravi Shankar Ayathu Venkata, Praveen Ghokale, Pavitra Chakravarty, Fahmina Anwar
Asia Pac Allergy. 2018;8(4):.    doi: 10.5415/apallergy.2018.8.e36.


Reference

1. Robbins KA, Wood RA, Keet CA. Milk allergy is associated with decreased growth in US children. J Allergy Clin Immunol. 2014; 134:1466–1468.e6.
Article
2. Vieira MC, Morais MB, Spolidoro JV, Toporovski MS, Cardoso AL, Araujo GT, et al. A survey on clinical presentation and nutritional status of infants with suspected cow' milk allergy. BMC Pediatr. 2010; 10:25.
Article
3. Vandenplas Y, Dupont C, Eigenmann P, Host A, Kuitunen M, Ribes-Koninckx C, et al. A workshop report on the development of the cow's milk-related symptom score awareness tool for young children. Acta Paediatr. 2015; 104:334–339.
Article
4. Vandenplas Y, Steenhout P, Planoudis Y, Grathwohl D. Althera Study Group. Treating cow's milk protein allergy: a double-blind randomized trial comparing two extensively hydrolysed formulas with probiotics. Acta Paediatr. 2013; 102:990–998.
Article
5. Vandenplas Y, De Greef E, Hauser B. Paradice Study Group. Safety and tolerance of a new extensively hydrolyzed rice protein-based formula in the management of infants with cow's milk protein allergy. Eur J Pediatr. 2014; 173:1209–1216.
Article
6. Vandenplas Y, De Greef E, Xinias I, Vrani O, Mavroudi A, Hammoud M, et al. Safety of a thickened extensive casein hydrolysate formula. Nutrition. 2016; 32:206–212.
Article
Full Text Links
  • PGHN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr